Quotient Investors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.14M Buy
14,654
+2,576
+21% +$214K 0.78% 51
2017
Q2
$1.07M Buy
12,078
+1,578
+15% +$133K 0.76% 51
2017
Q1
$846K Buy
10,500
+300
+3% +$23.4K 0.51% 61
2016
Q4
$727K Buy
10,200
+1,300
+15% +$102K 0.46% 73
2016
Q3
$769K Hold
8,900
0.5% 67
2016
Q2
$772K Sell
8,900
-100
-1% -$8.09K 0.36% 85
2016
Q1
$675K Buy
9,000
+5,728
+175% +$431K 0.25% 112
2015
Q4
$252K Hold
3,272
0.1% 193
2015
Q3
$219K Buy
+3,272
New +$241K 0.05% 185
2014
Q3
Sell
-4,000
Closed -$255K 272
2014
Q2
$255K Sell
4,000
-5,600
-58% -$340K 0.06% 222
2014
Q1
$591K Buy
+9,600
New +$559K 0.13% 166

Other funds holding MDT

Quotient Investors's MDT Position: Q3 2017 in Review

Quotient Investors increased its Medtronic (MDT) stake by 21% in Q3 2017, buying an estimated $214K and bringing the position to 14,654 shares worth $1.14M. The position accounts for 0.78% of the portfolio, ranked #51.

Quotient Investors first reported a position in MDT in Q1 2014 and has held it in 11 quarters since. 1,291 funds tracked by Wall St. Rank hold MDT as of Q3 2017.

  • Quotient Investors held 14,654 shares of Medtronic worth $1.14M as of Q3 2017.
  • Quotient Investors bought 2,576 Medtronic shares in Q3 2017, an estimated $214K.
  • Medtronic made up 0.78% of Quotient Investors's portfolio in Q3 2017, its #51 holding.
  • Quotient Investors first reported a position in Medtronic in Q1 2014 and has held it in 11 quarters since.
  • 1,291 funds tracked by Wall St. Rank held Medtronic as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.